NCT07734870 clinical trial report covering Tirzepatide, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07733934 clinical trial report covering Teverelix Trifluoroacetate, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07733180 clinical trial report covering Tislelizumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07734038 clinical trial report covering Venetoclax, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07737925 clinical trial report covering Xaluritamig, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20262884 clinical trial report covering HX9428, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20262897 clinical trial report covering Albipagrastim alfa, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20262849 clinical trial report covering XH-S003, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07737795 clinical trial report covering Paclitaxel, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07737743 clinical trial report covering DDY-391, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20262977 clinical trial report covering Pembrolizumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07735624 clinical trial report covering Botensilimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.